Optimizing Digital Health Technology Interventions to Increase Skill Acquisition and Utilization
Launched by DREXEL UNIVERSITY · Jul 21, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how certain digital health tools can help people with bulimia nervosa and binge eating disorder improve their eating habits. Researchers want to find out which combination of self-monitoring techniques and small interventions, when added to standard therapy, works best for helping individuals learn and use new skills related to their eating behaviors. They'll track the participants' progress not just during the treatment but also at follow-ups after 6 and 12 months to see how effective these tools are over time.
To join the study, participants should have experienced at least 12 episodes of losing control over their eating in the past three months and have a body mass index (BMI) of 18.5 or higher. They also need to be located in the U.S. and able to give consent for participation. However, people who are currently receiving treatment for an eating disorder, have certain medical or psychological issues, or are pregnant cannot participate. Those who are eligible can expect to engage with new digital tools designed to support their treatment and will be monitored for their progress throughout the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Have experienced 12 or more loss of control episodes within the previous 3 months
- • 2. Have a BMI at or above 18.5
- • 3. Are located in the US and willing/able to participate in treatment and assessments
- • 4. Are able to give consent
- Exclusion Criteria:
- • 1. Are unable to fluently speak, write and read English
- • 2. Have a BMI below 18.5
- • 3. Are already receiving treatment for an eating disorder
- • 4. Require immediate treatment for medical complications as a result of eating disorder symptoms
- • 5. Have a mental handicap, or are experiencing other severe psychopathology that would limit the participants' ability to comply with the demands of the current study (e.g. severe depression with suicidal intent, active psychotic disorder, severe substance use)
- • 6. Are pregnant or are planning to become pregnant
About Drexel University
Drexel University is a prominent research institution located in Philadelphia, Pennsylvania, known for its commitment to advancing knowledge through innovative research and education. As a clinical trial sponsor, Drexel University leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical research aimed at improving health outcomes. The university fosters collaborations across various fields, including medicine, engineering, and public health, ensuring a comprehensive approach to addressing complex health challenges. With a focus on ethical standards and participant safety, Drexel University is dedicated to translating research findings into practical applications that enhance community well-being and contribute to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Patients applied
Trial Officials
Adrienne S Juarascio, Ph.D.
Principal Investigator
Drexel University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials